SCOPUS 정보 검색 플랫폼

Volumn 27, Issue 6, 2000, Pages 761-764

Proposed standard nomenclature for new tumor necrosis factor members involved in the regulation of bone resorption

(41) Lawrence Riggs, B a Baron, Roland b Boyle, William J c John Martin, T d Suda, Tatsuo e Yasuda, Hisataka f Boyce, Brendan F g Brandi, Maria Luisa h Broadus, Arthur E i Chambers, Timolthy J j Delmas, Pierre D k Dempster, David W l Felix, Rolf m Fleisch, Herbert A m Findlay, David M n Fujita, Toshiro o Kato, Shigeaki o Tanaka, Sakae o Gay, Carol V p Gilespie, Matthew T q more..

a MAYO CLINIC (United States)

b Bone Spine and Hand Surgery Chartered (United States)

c AMGEN INC (United States)

d UNIVERSITY OF MELBOURNE (Australia)

e SHOWA UNIVERSITY (Japan)

f SNOW BRAND MILK PRODUCTS CO LTD (Japan)

g UNIVERSITY OF ROCHESTER (United States)

h UNIVERSITY OF FLORENCE (Italy)

i YALE UNIVERSITY (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ARTICLE; HUMAN; NOMENCLATURE; OSTEOLYSIS; SIGNAL TRANSDUCTION;

BONE RESORPTION; CARRIER PROTEINS; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TERMINOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033679142 PISSN: 87563282 EISSN: None Source Type: Journal
DOI: 10.1016/S8756-3282(00)00420-8 Document Type: Article

Times cited : (20)

References (19)

1
- 84992283672
- Roodman G. D. Advances in bone biology: The osteoclast. Endocr Rev 17:308-332; 1996

2
- 0001137929
- Modulation of osteoclast differentiation; Update 1995
- (1995) Endocr Rev , vol.4 , pp. 266-270
- Suda, T.¹ Takahasi, N.² Martin, T.J.³

3
- 0032471079
- Interleukins in the control of osteoclast differentiation
- (1998) Crit Rev. Eukaryot Gene Exper , vol.8 , pp. 107-123
- Martin, T.J.¹ Romas, E.² Gillespie, M.T.³

4
- 0022578909
- Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone
- (1986) Endocrinology , vol.118 , pp. 824-828
- McSheehy, P.M.J.¹ Chamber, T.J.²

5
- 0024435957
- The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells
- (1989) Endocrinology , vol.125 , pp. 1805-1813
- Udagawa, N.¹ Takahashi, N.² Akatsu, T.³ Sasaki, T.⁴ Yamaguchi, A.⁵ Kodama, H.⁶ Martin, T.J.⁷ Suda, T.⁸

6
- 0033304730
- Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
- (1999) Endocr Rev , vol.20 , pp. 345-357
- Suda, T.¹ Takahashi, N.² Udagawa, N.³ Jimi, E.⁴ Gillespie, M.T.⁵ Martin, T.J.⁶

7
- 0033984313
- The roles of osteoprotegenin and osteoprotegerin ligand in the paracrine regulation of bone resorption
- (2000) J. Bone Miner Res , vol.15 , pp. 2-12
- Hofbauer, L.C.¹ Khosla, S.² Dunstan, C.R.³ Lacey, D.L.⁴ Boyle, W.J.⁵ Riggs, B.L.⁶

8
- 84992257525
- Simonet W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H. L., Trail, G., Sullivan, J. Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T. M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., Amgen, EST Program, and Boyle, W. J. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319; 1997

9
- 0030989969
- Isolation of a novel cytokine from human fibroblasts that specificaly inhibits osteoclasto-genesis
- (1997) Biochem Biophys Res Commun , vol.234 , pp. 137-142
- Tsuda, E.¹ Goto, M.² Mochizuki, S.³ Yano, K.⁴ Kobayashi, F.⁵ Morinaga, T.⁶ Higashio, K.⁷

10
- 84992231622
- Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T., and Higashio, K. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337; 1998. Ensrud, K., Genant, H. K., Palermo, L., Scott, J., and Vogt, T. M. Bone density at various sites for prediction of hip fracture. Lancet 341:72-75; 1993

11
- 17344381882
- TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption
- (1998) FASEB J , vol.12 , pp. 845-854
- Kwon, B.S.¹ Wang, S.A.² Udagawa, N.³ Haridas, V.⁴ Lee, Z.H.⁵ Kim, K.K.⁶ Oh, K.O.⁷ Grene, J.⁸ Li, Y.⁹ Su, J.¹⁰ Gentz, R.¹¹ Aggarwal, B.B.¹² Ni, J.¹³

12
- 0032400933
- OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
- (1998) J. Immunol , vol.161 , pp. 6113-6121
- Yun, T.J.¹ Chaudhary, P.M.² Shu, G.L.³ Frazer, J.K.⁴ Ewings, M.K.⁵ Schwartz, S.M.⁶ Pascual, V.⁷ Hood, L.E.⁸ Clark, E.A.⁹

13
- 84992273973
- Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K., Udagawa, N., Takahashi, N., and Suda, T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Scie USA 95:3597-3602. calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 337:670-676; 1997

14
- 0032540319
- Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
- (1998) Cell , vol.93 , pp. 165-176
- Lacey, D.L.¹ Timms, E.² Tan, H.L.³ Dunstand, C.R.⁴ Burgess, T.⁵ Elliot, R.⁶ Colombero, A.⁷ Sullivan, J.⁸ Hawkins, N.⁹ Davy, E.¹⁰ Capparelli, C.¹¹ Eli, A.¹² Qian, Y.X.¹³ Kaufman, S.¹⁴ Sarosi, I.¹⁵ Shalhoub, V.¹⁶ Senaldi, G.¹⁷ Guo, J.¹⁸ Delaney, J.¹⁹ Boyle, W.J.²⁰ more..

15
- 14444272043
- TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
- (1997) J Biol Chem , vol.272 , pp. 25190-25194
- Wong, B.R.¹ Rho, J.² Arron, J.³ Robinson, E.⁴ Orlinick, J.⁵ Chao, M.⁶ Kalachikov, S.⁷ Cayani, E.⁸ Bartlett, F.S.⁹ Frankel, W.N.¹⁰ Lee, S.Y.¹¹ Choi, Y.¹²

16
- 0030714605
- A homologue of the TNF receptor and its ligand enhance T-cell growth and dendristic-cell function
- (1997) Nature , vol.390 , pp. 175-179
- Anderson, D.M.¹ Maraskovsky, E.² Billingsley, W.L.³ Dougail, W.C.⁴ Tometsko, M.E.⁵ Roux, E.R.⁶ Teepe, M.C.⁷ Du Bose, R.F.⁸ Cosman, D.⁹ Galibert, L.¹⁰

17
- 0032545355
- RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis
- (1998) Biochem Biophys Res Commun , vol.253 , pp. 395-400
- Nakagawa, N.¹ Kinosaki, M.² Yamaguchi, K.³ Shima, N.⁴ Yasuda, H.⁵ Yano, K.⁶ Morinaga, T.⁷ Higashio, K.⁸

18
- 84992242165
- Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelly, M. J., Sarosi, I., Wang, L., Xia, X.-Z., Elliott, R., Chiu, L., Black, T., Scully, S., Capparelli, C., Morony, S., Shimamoto, G. Bass, M. B., and Boyle, W. J. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activiation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540!3545; 1999

19
- 84992247980
- TNF Nomenclature Scheme

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.